It has been approved in Switzerland and the US, in combination with vemurafenib for the treatment of patients with unresectable or metastatic BRAF V600 mutation-positive melanoma.. Reference standards of Cobimetinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
stdClass Object ( [pname] => Cobimetinib - API Standards [catalogue_number] => PA 56 64000 [category_ids] => ,80,71,78,70,82,121, [chemical_name] => [weight] => 531.31 [form] => C21H21F3IN3O2 [cas] => 934660-93-2 [pslug] => 934660-93-2-cobimetinib-api-pa5664000 [latest_product] => 0 [linkproducts] => 1 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 56 64000
CAS :
Molecular Formula : C21H21F3IN3O2
Molecular Weight : 531.31
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....